Adenovirus Vector Advances Immunogene Therapy for Liver Cancer
The invention regards the use of viral or adenoviral vectors for selective tumour thera-peutic methods of liver cell carcinoma in the form of an immunogene therapy.
Further Information: PDF
PVA Mecklenburg-Vorpommern AG
Phone: +49 (0)381/49 74 74 0
Contact
Antonio Martinez
